School of Pharmacy

The Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium has been awarded a $30.8M grant over five years to research the most effective treatment options for future clinical testing.

Diana Cowell, PharmD, MBA, leveraged her military and pharmacy experience from around the world to provide comprehensive medication management and become a specialist in pain management for veterans. 

In the annual Spring Research Seminar, current scientific posters created by School of Pharmacy faculty, staff, fellows, residents, and students are presented.

During the seminar, the creators of four posters are selected to receive the Gary Rifkind Award, each of which includes a prize of $1,000...

School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.

The fifth annual summit was UCSF-Stanford CERSI’s largest in-person meeting yet, showcasing the School’s commitment to the dynamic field of regulatory science in discussions with FDA center directors and past and present FDA commissioners.

Attend in person at Mission Bay or on Zoom at 3:30 p.m. Pacific on Tuesday, April 16. Reception to follow.

The GPCR and neuropsychiatric diseases researcher will receive $1.25 million over five years to explore new territory.

Channeling his passion for chemistry and computers into the ever-evolving landscape of pharmacy, Hearns has carved out his own lane.

The first program of its kind in the United States, the MS in AICD3 will enable its graduates to gain a competitive edge for some of the most desirable jobs in the biopharmaceutical industry and in academia.